// App-Quantinova.ai

: Relationship between health-related quality of life and objective cough frequency in a phase 2b trial of gefapixant

Researchers

Presenter

  • Surinder S. Birring

Principal Investigators

  • David Muccino

  • Elizabeth Bacci

  • Margaret Vernon

  • Jonathan Schelfhout

  • Allison M. Nguyen

Medical Centers

  • Kings College London, London, United Kingdom

  • Merck & Co., Inc., Kenilworth, United States of America

  • Evidera, Seattle, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Gefapixant

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

Phase

  • II

Study Id's

  • NCT02612610

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved